Cargando…

Reversal of Tumor Necrosis Factor Resistance in Tumor Cells by Adriamycin via Suppression of Intracellular Resistance Factors

Tumor necrosis factor (TNF) and various chemotherapeutic drugs show synergistic antitumor effects in vitro and in vivo, though the mechanism is not clear. Based on our previous finding that endogenous TNF (enTNF) acts as an intracellular resistance factor against exogenous TNF by scavenging oxygen f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Naoki, Okamoto, Tetsuro, Tsuji, Naoki, Sasaki, Hiroyoshi, Akiyama, Shinichiro, Kobayashi, Daisuke, Sato, Tsutomu, Yamauchi, Naofumi, Niitsu, Yoshiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1995
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920838/ https://www.ncbi.nlm.nih.gov/pubmed/7775261 http://dx.doi.org/10.1111/j.1349-7006.1995.tb03069.x

Ejemplares similares

Mechanism of Synergistic Cytotoxic Effect between Tumor Necrosis Factor and Hyperthermia
por: Yamauchi, Naofumi, et al.
Publicado: (1992)

Enhancement of Lysosomal Enzyme Activity by Recombinant Human Tumor Necrosis Factor and Its Role in Tumor Cell Killing in vitro
por: Watanabe, Naoki, et al.
Publicado: (1992)

Induction of Synthesis of Heat Shock Protein 72 in Tumor Necrosis Factor Gene‐transduced Cells
por: Watanabe, Naoki, et al.
Publicado: (1994)

Enhanced Antitumor Effect of Recombinant Human Tumor Necrosis Factor in Combination with Recombinant Human Granulocyte Colony‐stimulating Factor in BALB/c Mice
por: Maeda, Masahiro, et al.
Publicado: (1993)

Enhancement of Blood Stasis and Vascular Permeability in Meth‐A Tumors by Administration of Hyperthermia in Combination with Tumor Necrosis Factor
por: Umeno, Hiroshi, et al.
Publicado: (1994)

Synergistic Suppressive Effect of Double Transfection of Tumor Necrosis Factor‐α and Interleukin 12 Genes on Tumorigenicity of Meth‐A Cells
por: Fujiwara, Hitoshi, et al.
Publicado: (2000)

Augmented Adriamycin Sensitivity in Cells Transduced with an Antisense Tumor Necrosis Factor Gene Is Mediated by Caspase‐3 Downstream from Reactive Oxygen Species
por: Sasaki, Masahiro, et al.
Publicado: (2001)

Lysosome Labilizers Potentiate the Antitumor Effects of Tumor Necrosis Factor‐α
por: Masegi, Tsukio, et al.
Publicado: (1993)

Human Tumor–infiltrating Lymphocytes Transfected with Tumor Necrosis Factor Gene Could Augment Cytotoxicity to Autologous Tumor Cells
por: Itoh, Yoshinori, et al.
Publicado: (1991)

Characterization of a Novel Human Tumor Necrosis Factor‐α Mutant with Increased Cytotoxic Activity
por: Masegi, Tsukio, et al.
Publicado: (1995)

Augmented Systemic Immunity in Mice Implanted with Tumor Necrosis Factor‐α Gene‐transduced Meth‐A Cells
por: Fujii, Shigeyuki, et al.
Publicado: (1994)

Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor
Publicado: (1986)

Doxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cells
por: Diao, Yuan-Yuan, et al.
Publicado: (2011)

In vivo Anti‐tumor Efficacy of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α against Tumor Necrosis Factor‐resistant Tumors
por: Tsutsumi, Yasuo, et al.
Publicado: (1996)

Circumvention of Atypical Multidrug Resistance with Tumor Necrosis Factor
por: Cimoli, Guido, et al.
Publicado: (1994)

Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer
por: Mukaida, Naofumi, et al.
Publicado: (2011)

Keratin-Dependent, Epithelial Resistance to Tumor Necrosis Factor-Induced Apoptosis
por: Caulin, Carlos, et al.
Publicado: (2000)

Intracellular Metabolism and Cytotoxicity of Transferrin‐Neocarzinostatin Conjugates of Differing Molar Ratios
por: Sasaki, Katsunori, et al.
Publicado: (1993)

Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment()()
por: Gong, Ke, et al.
Publicado: (2020)

Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells
por: Sprowl, Jason A, et al.
Publicado: (2012)

Acquired Factor VIII Inhibitor in a Patient of Rheumatoid Arthritis on Tumor Necrosis Factor Inhibitor Therapy
por: Mori, Tomoyo, et al.
Publicado: (2018)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
por: Qi, Min, et al.
Publicado: (2021)

Tumor Necrosis Factor and Splenectomy
por: Yavaşoğlu, İrfan
Publicado: (2016)

Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents
por: Park, Jinkyeong, et al.
Publicado: (2023)

Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
por: Endo, S, et al.
Publicado: (2000)

Resistance of rheumatoid arthritis synovial fibroblasts to p38 MAP-kinase inhibition of pro-destructive functions mediated by tumor necrosis factor alpha/tumor necrosis factor receptor-1
por: Kunisch, E, et al.
Publicado: (2005)

Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment
por: Takazono, Takahiro, et al.
Publicado: (2016)

Inflammation, tumor necrosis factor, and toxicology.
por: Luster, M I
Publicado: (1998)

Tumor Necrosis Factor and Regulatory T Cells
por: Jung, Min Kyung, et al.
Publicado: (2019)

Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis
por: Atan, Denize, et al.
Publicado: (2013)

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
por: Fischer, Roman, et al.
Publicado: (2017)

The effect of capsaicin on circulating biomarkers, soluble tumor necrosis factor and soluble tumor necrosis factor-receptor-1 and -2 levels in vivo using lipopolysaccharide-treated mice
por: Ijiri, Yoshio, et al.
Publicado: (2014)

Atheroprotective Effects of Tumor Necrosis Factor–Stimulated Gene-6
por: Watanabe, Rena, et al.
Publicado: (2016)

Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line
por: Manh Hung, Le Van, et al.
Publicado: (2018)

Acute Induction of Adriamycin‐resistance in Human Colon Carcinoma HT‐29 Cells Exposed to a Sublethal Dose of Adriamycin
por: Tomida, Akihiro, et al.
Publicado: (1995)

Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Co-infection of macrophages modulates interferon gamma and tumor necrosis factor-induced activation against intracellular pathogens
Publicado: (1990)

Transdermal Delivery of Adriamycin to Transplanted Ehrlich Ascites Tumor in Mice
por: Shiozuka, Masataka, et al.
Publicado: (2013)

Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
por: Schaer, David A, et al.
Publicado: (2014)

Effects of Tumor Necrosis Factor and Hyperthermia on Meth‐A Tumors
por: Hiraoka, Masahiro, et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_7b9kse83dttq0t6a4816g3sro6